An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage

Cited by (1,002)

Items 201–300 of 1,002

1. Challenges and opportunities of cfDNA analysis implementation in clinical practice: Perspective of the International Society of Liquid Biopsy (ISLB)
   Christian Diego Rolfo, Andrés Felipe Cardona, Massimo Cristofanilli, Luis G Paz-Ares, Juan J. Díaz‐Mochon, Ignacio Durán, Luis Estuardo Raez, Alessandro Russo, Jose Antonio Lorente, Umberto Malapelle et al. · 2020 · Critical Reviews in Oncology/Hematology
2. Circulating biomarkers to monitor cancer progression and treatment
   Suthee Rapisuwon, Eveline E. Vietsch, Anton Wellstein · 2016 · Computational and Structural Biotechnology Journal
3. Circulating tumour DNA sequence analysis as an alternative to multiple myeloma bone marrow aspirates
   Olena Kis, Rayan Kaedbey, Signy Chow, Arnavaz Danesh, Mark Dowar, Tiantian Li, Zhihua Li, Jessica Liu, Mark Mansour, Esther Masih‐Khan et al. · 2017 · Nature Communications
4. Ultrasensitive plasma-based monitoring of tumor burden using machine-learning-guided signal enrichment
   Adam J. Widman, Minita J. Shah, Amanda Frydendahl, Daniel Halmos, Cole C. Khamnei, Nadia Øgaard, Srinivas Rajagopalan, Anushri Arora, Aditya S. Deshpande, William F. Hooper et al. · 2024 · Nature Medicine
5. Circulating free DNA concentration is an independent prognostic biomarker in lung cancer
   Claire Tissot, Anne‐Claire Toffart, Stéphanie Villar, Pierre-Jean Souquet, Patrick Merle, Denis Moro‐Sibilot, Maurice Pérol, Jiří Zavadil, Christian Brambilla, Magali Olivier et al. · 2015 · European Respiratory Journal
6. Monitoring Daily Dynamics of Early Tumor Response to Targeted Therapy by Detecting Circulating Tumor DNA in Urine
   Hatim Husain, Vladislava O. Melnikova, Karena A. Kosco, Brian D. Woodward, Soham More, Sandeep C. Pingle, Elizabeth Weihe, Ben Ho Park, Muneesh Tewari, Mark G. Erlander et al. · 2017 · Clinical Cancer Research
7. Liquid Biopsy in Head and Neck Cancer: Promises and Challenges
   T. Nonaka, David T. Wong · 2018 · Journal of Dental Research
8. Multiplexed enrichment of rare DNA variants via sequence-selective and temperature-robust amplification
   Lucia Ruojia Wu, Sherry Xi Chen, Yalei Wu, Abhijit A. Patel, David Yu Zhang · 2017 · Nature Biomedical Engineering
9. Serial ctDNA Monitoring to Predict Response to Systemic Therapy in Metastatic Gastrointestinal Cancers
   Aparna R. Parikh, Amikasra Mojtahed, Jaime Laurel Schneider, Katie N. Kanter, Emily E. Van Seventer, Isobel J. Fetter, Ashraf Thabet, Madeleine G. Fish, Bezaye Teshome, Kathryn D. Fosbenner et al. · 2020 · Clinical Cancer Research
10. Liquid Biopsies, Novel Approaches and Future Directions
    Athanasios Armakolas, Maria Kotsari, John S. Koskinas · 2023 · Cancers
11. Cell-free circulating tumor DNA in cancer
    Zhen Qin, Vladimir A. Ljubimov, Cuiqi Zhou, Yunguang Tong, Jimin Liang · 2016 · 癌症：英文版
12. Guide to detecting epidermal growth factor receptor (EGFR) mutations in ctDNA of patients with advanced non-small-cell lung cancer
    Nicola Normanno, Marc Guillaume Denis, Kenneth Stephen Thress, M. Ratcliffe, Martin Reck · 2016 · Oncotarget
13. From genetics to the clinic: a translational perspective on follicular lymphoma
    Sarah Huet, Pierre Sujobert, Gilles Salles · 2018 · Nature reviews. Cancer
14. Universal cancer screening: revolutionary, rational, and realizable
    Ahlquist, David A. · 2018 · npj Precision Oncology
15. Saliva Diagnostics
    T. NONAKA, David T. Wong · 2022 · Annual Review of Analytical Chemistry
16. Bridging biological cfDNA features and machine learning approaches
    Tina Moser, Stefan Kühberger, Isaac Lazzeri, Georgios Vlachos, Ellen Heitzer · 2023 · Trends in Genetics
17. Understanding the Basics of NGS: From Mechanism to Variant Calling
    Dale Muzzey, Eric Evans, Caroline Lieber · 2015 · Current Genetic Medicine Reports
18. Simple multiplexed PCR-based barcoding of DNA for ultrasensitive mutation detection by next-generation sequencing
    Anders Ståhlberg, Paul M. Krzyzanowski, Matthew Egyud, Stefan Filges, Lincoln David Stein, Tony E. Godfrey · 2017 · Nature Protocols
19. Global analysis of shared T cell specificities in human non-small cell lung cancer enables HLA inference and antigen discovery
    Chiou, Shin-Heng, Tseng, Diane, Reuben, Alexandre, Mallajosyula, Vamsee, Molina, Irene S., Conley, Stephanie, Wilhelmy, Julie, McSween, Alana M., Yang, Xinbo, Nishimiya, Daisuke et al. · 2021 · Immunity
20. Evaluation of an assay for methylated BCAT1 and IKZF1 in plasma for detection of colorectal neoplasia
    Susanne Kartin Pedersen, Erin Leigh Symonds, Rohan T. Baker, David H. Murray, Aidan McEvoy, Sascha C. van Doorn, Marco William Mundt, Stephen R. Cole, Geetha L. Gopalsamy, Dileep Mangira et al. · 2015 · BMC Cancer
21. Potential Utility of Liquid Biopsy as a Diagnostic and Prognostic Tool for the Assessment of Solid Tumors: Implications in the Precision Oncology
    Roshni Ann Mathai, Ryali Valli Sri Vidya, B. Shrikar Reddy, Levin Thomas, Karthik Udupa, Jill Kolesar, Mahadev Rao · 2019 · Journal of Clinical Medicine
22. Liquid biopsy for lung cancer early detection
    Mariacarmela Santarpía, Alessia Liguori, Alessandro D’Aveni, Niki Karachaliou, María González‐Cao, Maria Grazia Daffinà, Chiara Lazzari, Giuseppe Altavilla, Rafael Rosell · 2018 · Journal of Thoracic Disease
23. Impact of KRAS mutation subtype and concurrent pathogenic mutations on non-small cell lung cancer outcomes
    Jacqueline V. Aredo, Sukhmani Kaur Padda, Christian A. Kunder, Summer S. Han, Joel W. Neal, Joseph B. Shrager, Heather A. Wakelee · 2019 · Lung Cancer
24. Small extracellular vesicles in cancer
    Komal K. Abhange, Amy Makler, Yi Wen, Natasha Ramnauth, Wenjun Mao, Waseem Asghar, Yuan Wan · 2021 · Bioactive Materials
25. Current and future applications of liquid biopsy in nonsmall cell lung cancer from early to advanced stages
    Nicolas Marie Guibert, Anne Pradines, Gilles Favre, Julien Mazières · 2020 · European Respiratory Review
26. Circulating Tumor DNA Profiling for Detection, Risk Stratification, and Classification of Brain Lymphomas
    Jurik Mutter, Stefan Alig, Mohammad Shahrokh Esfahani, Eliza Maria Lauer, Jan Mitschke, David M. Kurtz, Julia Kühn, Sabine Bleul, Mari N. Olsen, Chih Long Liu et al. · 2022 · Journal of Clinical Oncology
27. Cell-free DNA as a diagnostic marker for cancer: current insights
    Samanta Salvi, Giorgia Gurioli, Ugo De Giorgi, Vincenza Conteduca, Gianluca Tedaldi, Daniele Calistri, Valentina Casadio · 2016 · OncoTargets and Therapy
28. Liquid Biopsy in Glioblastoma: Opportunities, Applications and Challenges
    Ander Saenz‐Antoñanzas, Jaione Auzmendi-Iriarte, Estefanía Carrasco‐García, Leire Moreno‐Cugnon, Irune Ruiz, Jorge Villanúa, Larraitz Egaña, David Otaegui, Nicolàs Samprón, Ander Matheu · 2019 · Cancers
29. The value of cell‐free DNA for molecular pathology
    Caitlin M. Stewart, Prachi D. Kothari, Florent C. Mouliere, Richard James Mair, Saira Somnay, Ryma Benayed, Ahmet Zehir, Britta Weigelt, Sarah‐Jane Dawson, Maria E. Arcila et al. · 2018 · The Journal of Pathology
30. Circulating Tumor DNA Analysis to Assess Risk of Progression after Long-term Response to PD-(L)1 Blockade in NSCLC
    Matthew David Hellmann, Barzin Y. Nabet, Hira A. Rizvi, Aadel A. Chaudhuri, Daniel K. Wells, Mark P. Dunphy, Jacob J. Chabon, Chih Long Liu, Angela Bik‐Yu Hui, Kathryn Cecilia Arbour et al. · 2020 · Clinical Cancer Research
31. Entropy Beacon: A Hairpin-Free DNA Amplification Strategy for Efficient Detection of Nucleic Acids
    Yifan Lv, Liang Cui, Ruizi Peng, Zilong Zhao, Liping Qiu, Huapei Chen, Cheng Yu Jin, Xiaobing Zhang, Weihong Tan · 2015 · Analytical Chemistry
32. Liquid Biopsy in Clinical Management of Breast, Lung, and Colorectal Cancer
    Ivana Bratić Hench, Jürgen Hench, Markus Tolnay · 2018 · Frontiers in Medicine
33. A Prospective Study of Circulating Tumor DNA to Guide Matched Targeted Therapy in Lung Cancers
    Joshua K. Sabari, Michael David Offin, Dennis P. Stephens, Ai Ni, Adrian V. Lee, Nick Pavlakis, Stephen John Clarke, Connie Irene Diakos, Sutirtha Datta, Nidhi Tandon et al. · 2018 · JNCI Journal of the National Cancer Institute
34. Plasma cell-free DNA (cfDNA) as a predictive and prognostic marker in patients with metastatic breast cancer
    Daniel Fernández-García, Allison Hills, Karen Page, Robert K. Hastings, Bradley J. Toghill, Kate S. Goddard, Charlotte Ion, Olivia Ogle, Anna Boydell, Kelly L. T. Gleason et al. · 2019 · Breast Cancer Research
35. Circulating tumor DNA detection in lung cancer patients before and after surgery
    Nannan Guo, Feng Lou, Yongfu Ma, Jie Li, Bo Yang, Wei Chen, Hua Ye, Jing-Bo Zhang, Ming-Yu Zhao, Wenjun Wu et al. · 2016 · Scientific Reports
36. Circulating breast-derived DNA allows universal detection and monitoring of localized breast cancer
    Joshua Moss, Aviad Zick, Albert Grinshpun, Einat Carmon, Myriam Maoz, Bracha Lea Ochana, OBAYOMI Adesoji Abraham, O. Arieli, Lili Germansky, K. Meir et al. · 2020 · Annals of Oncology
37. Senescence in cancer
    Manuel Colucci, Miles Sarill, Martino Maddalena, Aurora Valdata, Martina Troiani, Martina Massarotti, Marco Bolis, Silvia Bressan, Anna Kohl, Daniele Robesti et al. · 2025 · Cancer Cell
38. Circulating Tumor DNA Detection in Early-Stage Non-Small Cell Lung Cancer Patients by Targeted Sequencing
    Kezhong Chen, Feng Lou, Fan Yang, Jingbo Zhang, Hua Ye, Wei Chen, Tian Guan, Ming-Yu Zhao, Xue-Xia Su, Rong Shi et al. · 2016 · Scientific Reports
39. Next-generation sequencing of circulating tumor DNA to predict recurrence in triple-negative breast cancer patients with residual disease after neoadjuvant chemotherapy
    Yu-Hsiang Chen, Bradley Allen Hancock, Jeffrey P. Solzak, Dumitru Brinza, Charles Scafe, Kathy D. Miller, Milan Radovich · 2017 · npj Breast Cancer
40. Combining precision radiotherapy with molecular targeting and immunomodulatory agents: a guideline by the American Society for Radiation Oncology
    Robert Glen Bristow, Brian Michael Alexander, Michael A. Baumann, Scott Victor Bratman, J. Martin Brown, Kevin A. Camphausen, Peter L. Choyke, Deborah E. Citrin, Joseph N. Contessa, Adam Paul Dicker et al. · 2018 · The Lancet Oncology
41. KRAS G12C in advanced NSCLC: Prevalence, co-mutations, and testing
    Tony Kiat Hon Lim, Ferdinandos Skoulidis, Keith M. Kerr, Myung‐Ju Ahn, Joshua R. Kapp, Fernando Augusto Soares, Yasushi Yatabe · 2023 · Lung Cancer
42. Use of ctDNA in early breast cancer: analytical validity and clinical potential
    François Panet, Andri Papakonstantinou, María Borrell, Joan Vivancos, Ana P. Vivancos, Mafalda Oliveira · 2024 · npj Breast Cancer
43. Next Generation Sequencing of Circulating Cell-Free DNA for Evaluating Mutations and Gene Amplification in Metastatic Breast Cancer
    Karen Page, David S. Guttery, Daniel Fernández-García, Allison Hills, Robert K. Hastings, Jinli Luo, Kate S. Goddard, Vedia Shahin, Laura Woodley-Barker, Brenda Maria Rosales et al. · 2016 · Clinical Chemistry
44. Nanoplasmonic sensors for detecting circulating cancer biomarkers
    Abdul Rahim Ferhan, Joshua A. Jackman, Jae Hyeon Park, Nam‐Joon Cho, Dong‐Hwan Kim · 2017 · Advanced Drug Delivery Reviews
45. Molecular pathology of lung cancer: current status and perspectives
    Felicitas Oberndorfer, Leonhard Müllauer · 2017 · Current Opinion in Oncology
46. Clinical Utility of Plasma Cell-Free DNA in Adult Patients with Newly Diagnosed Glioblastoma: A Pilot Prospective Study
    Stephen Joseph Bagley, Seyed Ali Nabavizadeh, Jazmine J. Mays, Jacob Edward Till, Jeffrey B. Ware, Scott C Levy, Whitney Sarchiapone, Jasmin Hussain, Timothy Prior, Samantha Guiry et al. · 2019 · Clinical Cancer Research
47. Rapid Identification of Plasma DNA Samples with Increased ctDNA Levels by a Modified FAST-SeqS Approach
    Jelena Belic, Marina Koch, Peter Ulz, Martina Auer, Teresa Gerhalter, Sumitra Mohan, Katja Fischereder, Edgar Petru, Thomas Bauernhofer, Jochen B. Geigl et al. · 2015 · Clinical Chemistry
48. Detection of Circulating Tumor DNA in Human Blood via DNA-Mediated Surface-Enhanced Raman Spectroscopy of Single-Walled Carbon Nanotubes
    Qifeng Zhou, Jing Zheng, Zhihe Qing, Mengjie Zheng, Jinfeng Yang, Sheng Yang, Le Ying, Ronghua Yang · 2016 · Analytical Chemistry
49. Tumor-derived DNA from pleural effusion supernatant as a promising alternative to tumor tissue in genomic profiling of advanced lung cancer
    Lin Tong, Ning Ding, Xiaoling Tong, Jiamin Li, Yong Zhang, Xiaodan Wang, Xiaobo Xu, Maosong Ye, Chun Li, Xue Wu et al. · 2019 · Theranostics
50. Circumventing intratumoral heterogeneity to identify potential therapeutic targets in hepatocellular carcinoma
    Ao Huang, Xin Zhao, Xin‐Rong Yang, Fuqiang Li, Xinlan Zhou, Kui Wu, Xin Zhang, Qi‐Man Sun, Ya Cao, Hongmei Zhu et al. · 2017 · Journal of Hepatology
51. Clinical applications of liquid biopsy as prognostic and predictive biomarkers in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
    Jie Li, Xu Han, Xiaona Yu, Zongzhen Xu, Guangsheng Yang, Bingqi Liu, Peng Xiu · 2018 · Journal of Experimental & Clinical Cancer Research
52. CRISPR/Cas9-based targeted genome editing for correction of recessive dystrophic epidermolysis bullosa using iPS cells
    J. Jackow, Zongyou Guo, Corey S. Hansen, Hasan Erbil Abaci, Y. Doucet, Jung U Shin, Ryota Hayashi, Dominick DeLorenzo, Yudai Kabata, Satoru Shinkuma et al. · 2019 · Proceedings of the National Academy of Sciences
53. Genetic and evolutionary patterns of treatment resistance in relapsed B-cell lymphoma
    Christopher K. Rushton, Sarah E. Arthur, Miguel Alcaide, Matthew C. Cheung, Aixiang Jiang, Krysta Mila Coyle, Kirstie L.S. Cleary, Nicole Thomas, Laura K. Hilton, Neil R. Michaud et al. · 2020 · Blood Advances
54. Integrating circulating-free DNA (cfDNA) analysis into clinical practice: opportunities and challenges
    Miguel García-Pardo, Maisam Makarem, Janice J.N. Li, Deirdre Kelly, Natasha B. Leighl · 2022 · British Journal of Cancer
55. Circulating tumour DNA (CtDNA) as a liquid biopsy for melanoma
    Calapre, Leslie, Warburton, Lydia, Millward, Michael, Ziman, Mel, Gray, Elin S. · 2017 · Cancer Letters
56. CUT-PCR: CRISPR-mediated, ultrasensitive detection of target DNA using PCR
    S H Lee, Jihyeon Yu, G-H Hwang, Sang‐Tae Kim, H S Kim, S Ye, Kyoungmi Kim, Juhee Park, D Y Park, Y-K Cho et al. · 2017 · Oncogene
57. Association Of Plasma And Urinary Mutant DNA With Clinical Outcomes In Muscle Invasive Bladder Cancer
    Keval Patel, Kristan E. van der Vos, Christopher G. Smith, Florent C. Mouliere, Dana W.Y. Tsui, J. Morris, Dineika Chandrananda, Francesco Marass, Daan A. van den Broek, David Edgar Neal et al. · 2017 · Scientific Reports
58. Predicting Radiotherapy Responses and Treatment Outcomes Through Analysis of Circulating Tumor DNA
    Aadel A. Chaudhuri, Michael Sargent Binkley, Evan C. Osmundson, Ash A. Alizadeh, Maximilian Diehn · 2015 · Seminars in Radiation Oncology
59. A pilot study of ultra-deep targeted sequencing of plasma DNA identifies driver mutations in hepatocellular carcinoma
    Ismaïl Labgaa, Carlos Villacorta-Martín, Delia D’Avola, Amanda J. Craig, Johann von Felden, Sebastião N. Martins-Filho, Daniela Sia, Ashley Stueck, Stephen C. Ward, Maria Isabel Fiel et al. · 2018 · Oncogene
60. Liquid Biopsy and Lung Cancer
    Pasquale Pisapia, Umberto Malapelle, Giancarlo Troncone · 2018 · Acta Cytologica
61. Liquid Biopsy, ctDNA Diagnosis through NGS
    Lin Chen, Xuzhu Liu, Bingyi Zheng, Rongqin Ke, Chi‐Meng Tzeng · 2021 · Life
62. Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling
    Stefan Alig, Mohammad Shahrokh Esfahani, Andrea Garofalo, Michael Yu Li, Cédric Rossi, Tim Flerlage, Jamie E. Flerlage, Ragini Adams, Michael Sargent Binkley, Navika Shukla et al. · 2023 · Nature
63. Pre-operative ctDNA predicts survival in high-risk stage III cutaneous melanoma patients
    Jenny Lee, Robyn P.M. Saw, John F. Thompson, Serigne Lo, Andrew John Spillane, Kerwin Frank Shannon, Jonathan R. Stretch, Julie R. Howle, Alexander Maxwell Menzies, Matteo Salvatore Carlino et al. · 2019 · Annals of Oncology
64. Liquid biopsy for therapy monitoring in early-stage non-small cell lung cancer
    Misako Nagasaka, Md. Hafiz Uddin, Mohammed Najeeb Al Hallak, Sarah B. Rahman, Suresh Kumar Balasubramanian, Ammar W. Sukari, Asfar Sohail Azmi · 2021 · Molecular Cancer
65. Heterogeneity and cancer.
    Kimberly H. Allison, George W. Sledge · 2014 · PubMed
66. Genomic Copy Number Profiling Using Circulating Free Tumor DNA Highlights Heterogeneity in Neuroblastoma
    Mathieu Chicard, Sandrine Boyault, Leo Colmet Daage, Wilfrid Richer, David Gentien, Gaëlle Pierron, Eve Lapouble, Angela Bellini, Nathalie Clément, Isabelle Iacono et al. · 2016 · Clinical Cancer Research
67. Droplet-Based Digital PCR
    Géraldine Perkins, Heng Lu, Fanny Garlan, Valérie Taly · 2016 · Advances in clinical chemistry
68. Assessing the Impact of Data Preprocessing on Analyzing Next Generation Sequencing Data
    Binsheng He, Rongrong Zhu, Huandong Yang, Qingqing Lu, Weiwei Wang, Lei Song, Xue Jun Sun, Guandong Zhang, Shijun Li, Jialiang Yang et al. · 2020 · Frontiers in Bioengineering and Biotechnology
69. Advances in lung cancer screening and early detection
    Caichen Li, Huiting Wang, Yu Jiang, Wenhai Fu, Xiwen Liu, Ran Zhong, Bo Cheng, Feng Zhu, Yang Xiang, Jianxing He et al. · 2022 · Cancer Biology and Medicine
70. Strategies for modern biomarker and drug development in oncology
    Alan David Smith, Desam Roda, Timothy Anthony Yap · 2014 · Journal of Hematology & Oncology
71. EGFR G796D mutation mediates resistance to osimertinib
    Di Zheng, Min Hu, Yu Bai, Xuehua Zhu, Xuesong Lu, Chunyan Wu, Jiying Wang, Li Liu, Zheng Wang, Jian Ni et al. · 2017 · Oncotarget
72. Biological background of the genomic variations of cf-DNA in healthy individuals
    J. Liu, X. Chen, J. Wang, Shumin Zhou, C.L. Wang, M.Z. Ye, X.Y. Wang, Yijun Song, Youwei Wang, liuping zhang et al. · 2018 · Annals of Oncology
73. Circulating cell-free DNA for non-invasive cancer management
    Caitlin M. Stewart, Dana W.Y. Tsui · 2018 · Cancer Genetics
74. Circulating nucleosomes as epigenetic biomarkers in pancreatic cancer
    Monika Posaric Bauden, Dorian Pamart, Daniel Ansari, Mariëlle Herzog, Mark Eccleston, Jake Micallef, Bodil Andersson, Roland E. Andersson · 2015 · Clinical Epigenetics
75. Exome Sequencing of Cell-Free DNA from Metastatic Cancer Patients Identifies Clinically Actionable Mutations Distinct from Primary Disease
    Timothy M. Butler, Katherine Johnson-Camacho, Myron Peto, Nicholas J. Wang, Tara A. Macey, James E. Korkola, Theresa M. Koppie, Christopher L. Corless, Joe W. Gray, Paul T. Spellman · 2015 · PLoS ONE
76. Nanomaterial Preparation by Extrusion through Nanoporous Membranes
    Peng Guo, Jing Huang, Yaping Zhao, Charles R. Martin, Richard N. Zare, Marsha A. Moses · 2018 · Small
77. Next-Generation Sequencing and Fluorescence in Situ Hybridization Have Comparable Performance Characteristics in the Analysis of Pancreaticobiliary Brushings for Malignancy
    Jonathan C. Dudley, Zongli Zheng, Thomas O. McDonald, Long P. Le, Dora C. Dias-Santagata, Darrell R. Borger, Julie M. Batten, Kathy Vernovsky, Brenda J. Sweeney, Ronald Arpin et al. · 2015 · Journal of Molecular Diagnostics
78. Considerations and quality controls when analyzing cell-free tumor DNA
    Gustav Johansson, Daniel Andersson, Stefan Filges, Junrui Li, Andreas Muth, Tony E. Godfrey, Anders Ståhlberg · 2019 · Biomolecular Detection and Quantification
79. A clinician’s handbook for using ctDNA throughout the patient journey
    Samantha Ourania Hasenleithner, Michael R. Speicher · 2022 · Molecular Cancer
80. The feasibility of using mutation detection in ctDNA to assess tumor dynamics
    Xin Yi, Jianhui Ma, Yanfang Guan, Rongrong Chen, Ling Mei Yang, Xuefeng Xia · 2017 · International Journal of Cancer
81. The evidence base for circulating tumour DNA blood-based biomarkers for the early detection of cancer: a systematic mapping review
    Ian A. Cree, Lesley Uttley, Helen Buckley Woods, Hugh Kikuchi, Anne Reiman, S Harnan, Becky L. Whiteman, Sian Taylor‐Phillips, Michael Paul Messenger, Angela Cox et al. · 2017 · BMC Cancer
82. Early Noninvasive Detection of Response to Targeted Therapy in Non–Small Cell Lung Cancer
    Jillian A. Phallen, Alessandro Leal, Brian D. Woodward, Patrick M. Forde, Jarushka Naidoo, Kristen Ashley Marrone, Julie Renee Brahmer, Jacob Fiksel, Jamie E. Medina, Stephen Cristiano et al. · 2018 · Cancer Research
83. Next-Generation Sequencing in High-Sensitive Detection of Mutations in Tumors
    Rajesh R. Singh · 2020 · Journal of Molecular Diagnostics
84. Early assessment of circulating tumor DNA after curative‐intent resection predicts tumor recurrence in early‐stage and locally advanced non‐small‐cell lung cancer
    Silvia Waldeck, Jan Mitschke, Sebastian D. Wiesemann, Michael P. Rassner, Geoffroy Andrieux, Max Deuter, Jurik Mutter, Anne‐Marie Lüchtenborg, Daniel Kottmann, Laurin Titze et al. · 2021 · Molecular Oncology
85. Circulating tumor DNA predicts neoadjuvant immunotherapy efficacy and recurrence-free survival in surgical non-small cell lung cancer patients
    Dongsheng Yue, Weiran Liu, Chen Chen, Tao Zhang, Yuchen Ma, Longgang Cui, Yajun Gu, Ting Bei, Xiaochen Zhao, Bei Zhang et al. · 2022 · Translational Lung Cancer Research
86. Early cancer detection by serum biomolecular fingerprinting spectroscopy with machine learning
    Shilian Dong, Dong He, Qian Zhang, Chaoning Huang, Zhiheng Hu, Chenyang Zhang, Lei Nie, Kun Wang, Wei Luo, Jing Xia Yu et al. · 2023 · eLight
87. Circulating Tumor Cells: Fluid Surrogates of Solid Tumors
    Thiele, J.-A., Bethel, K., Králíčková, M., Kuhn, P. · 2017 · Annual Review of Pathology: Mechanisms of Disease
88. Inhibition of IL1β by Canakinumab May Be Effective against Diverse Molecular Subtypes of Lung Cancer: An Exploratory Analysis of the CANTOS Trial
    Connie C. Wong, Jason Baum, Angela Silvestro, Michael T. Beste, Bharani Dharan, Siyan Xu, Ying A. Wang, Tony Wang, MARGARET FORNEY PRESCOTT, Lynne Krajkovich et al. · 2020 · Cancer Research
89. Using cfDNA and ctDNA as Oncologic Markers: A Path to Clinical Validation
    Jonathan Dao, Patrick Conway, Baskaran Subramani, Devi Meyyappan, Sammy Russell, Daruka Mahadevan · 2023 · International Journal of Molecular Sciences
90. Liquid biopsy based biomarkers in non-small cell lung cancer for diagnosis and treatment monitoring
    David Pérez-Callejo, Atocha Romero, Mariano Provencio, María Torrente · 2016 · Translational Lung Cancer Research
91. The Role of Liquid Biopsy in Early Diagnosis of Lung Cancer
    Cláudia Freitas, Catarina Sousa, Francisco Machado, Mariana Serino, Vanessa Santos, Natália Alves Martins, Armando Teixeira, António Manuel Trigueiros da Silva Cunha, Tânia Pereira, Hélder P. Oliveira et al. · 2021 · Frontiers in Oncology
92. Tumor-Naïve Multimodal Profiling of Circulating Tumor DNA in Head and Neck Squamous Cell Carcinoma
    Justin Burgener, Jinfeng Zou, Zhen Zhao, Yangqiao Zheng, Shu Yi Shen, Shao Hui Huang, Sareh Keshavarzi, Wei Xu, Fei‐Fei Liu, Geoffrey Liu et al. · 2021 · Clinical Cancer Research
93. Circulating tumor DNA identified by targeted sequencing in advanced-stage non-small cell lung cancer patients
    Song Xu, Feng Lou, Yi Wu, Daqiang Sun, Jingbo Zhang, Wei Chen, Hua Ye, Jing-Hao Liu, Sen Wei, Mingyu Zhao et al. · 2015 · Cancer Letters
94. Circulating tumor DNA analyses predict progressive disease and indicate trastuzumab-resistant mechanism in advanced gastric cancer
    Yan Wang, Chuanhua Zhao, Lianpeng Chang, Ru Jia, Rongrui Liu, Yun Zhang, Xuan Gao, Jin Li, Rongrong Chen, Xuefeng Xia et al. · 2019 · EBioMedicine
95. Genome-wide plasma DNA methylation features of metastatic prostate cancer
    Anjui Wu, Paolo Cremaschi, Daniel Wetterskog, Vincenza Conteduca, Gian Marco Franceschini, Dimitrios Kleftogiannis, Anuradha Jayaram, Shahneen Kaur Sandhu, Stephen Q. Wong, Matteo Benelli et al. · 2020 · Journal of Clinical Investigation
96. A machine learning approach for somatic mutation discovery
    Derrick E. Wood, James Robert White, Andrew P. Georgiadis, Beth Van Emburgh, Sonya T. Parpart-Li, Jason Mitchell, Valsamo Anagnostou, Noushin Niknafs, Rachel Karchin, Eniko Papp et al. · 2018 · Science Translational Medicine
97. Perioperative circulating tumor DNA as a potential prognostic marker for operable stage I to IIIA non–small cell lung cancer
    Ning Li, Bao-Xiao Wang, Jian Li, Yang Washington Shao, Ming‐Tian Li, Jianjun Li, Peng‐Peng Kuang, Zui Liu, Tianyu Sun, Hui-qi Wu et al. · 2021 · Cancer
98. Genomic approaches to cancer and minimal residual disease detection using circulating tumor DNA
    Nicholas P. Semenkovich, Jeffrey J. Szymanski, Noah J. Earland, Pradeep S. Chauhan, Bruna Pellini, Aadel A. Chaudhuri · 2023 · Journal for ImmunoTherapy of Cancer
99. Application of Plasma Genotyping Technologies in Non–Small Cell Lung Cancer: A Practical Review
    Adrian Gerold Sacher, Kimberly Mayumi Komatsubara, Geoffrey R. Oxnard · 2017 · Journal of Thoracic Oncology
100. EGFR as a Pharmacological Target in EGFR -Mutant Non-Small-Cell Lung Cancer: Where Do We Stand Now?
     Erjing Ke, Yi-Long Lung Cancer Wu · 2016 · Trends in Pharmacological Sciences